Directors Team

The Directors Team at Immune-Onc Therapeutics is responsible for strategic decision-making and overseeing various aspects of the company's operations. This includes guiding clinical development, preclinical research, bioanalytical assessments, and overall project management to ensure the successful advancement of novel myeloid checkpoint inhibitors through the drug development pipeline. They collaborate closely to align the company's scientific, clinical, and business objectives.